| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.2 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |